CVS Health Corporation $CVS Shares Sold by Curbstone Financial Management Corp

Curbstone Financial Management Corp trimmed its stake in shares of CVS Health Corporation (NYSE:CVS) by 7.5% during the second quarter, Holdings Channel reports. The firm owned 15,478 shares of the pharmacy operator’s stock after selling 1,250 shares during the period. Curbstone Financial Management Corp’s holdings in CVS Health were worth $1,068,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently added to or reduced their stakes in the company. Harbor Asset Planning Inc. acquired a new position in shares of CVS Health during the 2nd quarter valued at $30,000. Bell Investment Advisors Inc grew its holdings in shares of CVS Health by 119.8% during the first quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock valued at $31,000 after buying an additional 248 shares in the last quarter. Roxbury Financial LLC grew its holdings in shares of CVS Health by 78.3% during the second quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock valued at $32,000 after buying an additional 202 shares in the last quarter. ORG Partners LLC boosted its position in CVS Health by 418.9% during the second quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator’s stock valued at $32,000 after purchasing an additional 377 shares during the last quarter. Finally, Saudi Central Bank acquired a new stake in CVS Health during the first quarter valued at $34,000. 80.66% of the stock is currently owned by institutional investors and hedge funds.

CVS Health Price Performance

Shares of NYSE CVS opened at $82.64 on Friday. The stock has a market capitalization of $104.81 billion, a price-to-earnings ratio of 23.08, a PEG ratio of 0.90 and a beta of 0.60. The business has a 50-day moving average of $74.00 and a 200-day moving average of $68.12. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.80 and a quick ratio of 0.62. CVS Health Corporation has a fifty-two week low of $43.56 and a fifty-two week high of $82.88.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Thursday, July 31st. The pharmacy operator reported $1.81 EPS for the quarter, topping analysts’ consensus estimates of $1.46 by $0.35. The business had revenue of $98.92 billion during the quarter, compared to analysts’ expectations of $94.87 billion. CVS Health had a return on equity of 10.51% and a net margin of 1.17%.CVS Health’s quarterly revenue was up 8.4% on a year-over-year basis. During the same quarter last year, the company posted $1.83 earnings per share. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. As a group, sell-side analysts predict that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, November 3rd. Stockholders of record on Thursday, October 23rd will be given a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.2%. The ex-dividend date is Thursday, October 23rd. CVS Health’s payout ratio is presently 74.30%.

Insider Buying and Selling at CVS Health

In other news, Director Anne A. Finucane sold 7,500 shares of CVS Health stock in a transaction that occurred on Wednesday, August 20th. The shares were sold at an average price of $71.02, for a total value of $532,650.00. Following the completion of the sale, the director directly owned 22,156 shares in the company, valued at approximately $1,573,519.12. The trade was a 25.29% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 1.22% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on the company. Wells Fargo & Company lifted their price objective on CVS Health from $84.00 to $103.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 7th. Cantor Fitzgerald restated an “overweight” rating and set a $78.00 price target on shares of CVS Health in a research note on Tuesday, August 26th. The Goldman Sachs Group began coverage on CVS Health in a research note on Tuesday. They set a “buy” rating and a $91.00 price target on the stock. Baird R W upgraded CVS Health from a “hold” rating to a “strong-buy” rating in a research note on Thursday, August 14th. Finally, Morgan Stanley boosted their price target on CVS Health from $82.00 to $89.00 and gave the company an “overweight” rating in a research note on Tuesday. Two investment analysts have rated the stock with a Strong Buy rating, twenty have given a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $82.57.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.